Untangling Amyloid-β, Tau, and Metals in Alzheimer's Disease

被引:343
|
作者
Savelieff, MG
Lee, S
Liu, YZ
Lim, MH [1 ]
机构
[1] Univ Michigan, Inst Life Sci, Ann Arbor, MI 48109 USA
[2] Univ Michigan, Dept Chem, Ann Arbor, MI 48109 USA
基金
美国国家科学基金会;
关键词
A-BETA; OXIDATIVE STRESS; STRUCTURAL-CHARACTERIZATION; NEUROFIBRILLARY TANGLES; IN-VIVO; PROTEIN; AGGREGATION; PEPTIDE; BINDING; PHOSPHORYLATION;
D O I
10.1021/cb400080f
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Protein misfolding and metal ion dyshomeostasis are believed to underlie numerous neurodegenerative diseases, including Alzheimer's disease (AD). The pathological hallmark of AD is accumulation of misfolded amyloid-beta (A beta) peptides and hyperphosphorylated tau (ptau) proteins in the brain. Since AD etiology remains unclear, several hypotheses have emerged to elucidate its pathological pathways. The amyloid cascade hypothesis, a leading hypothesis for AD development, advocates A beta as the principal culprit. Additionally, evidence suggests that tau may contribute to AD pathology. A beta and tau have also been shown to impact each other's pathology either directly or indirectly. Furthermore, metal ion dyshomeostasis is associated with these misfolded proteins. Metal interactions with A beta and tau/ptau also influences their aggregation properties and neurotoxicity. Herein, we present current understanding on the roles of A beta, tau, and metal ions, placing equal emphasis on each of these proposed features, as well as their inter-relationships in AD pathogenesis.
引用
收藏
页码:856 / 865
页数:10
相关论文
共 50 条
  • [1] Untangling the association of amyloid-β and tau with synaptic and axonal loss in Alzheimer's disease
    Pereira, Joana B.
    Janelidze, Shorena
    Ossenkoppele, Rik
    Kvartsberg, Hlin
    Brinkmalm, Ann
    Mattsson-Carlgren, Niklas
    Stomrud, Erik
    Smith, Ruben
    Zetterberg, Henrik
    Blennow, Kaj
    Hansson, Oskar
    BRAIN, 2021, 144 : 310 - 324
  • [2] Pathogenesis of Alzheimer's Disease: Role of Amyloid-β and Hyperphosphorylated Tau Protein
    Sajjad, Rabia
    Arif, Rawaba
    Shah, A. A.
    Manzoor, I.
    Mustafa, G.
    INDIAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2018, 80 (04) : 581 - 591
  • [3] Amyloid-β and Tau at the Crossroads of Alzheimer's Disease
    Gallardo, Gilbert
    Holtzman, David M.
    TAU BIOLOGY, 2019, 1184 : 187 - 203
  • [4] Yeast Model of Amyloid-β and Tau Aggregation in Alzheimer's Disease
    Moosavi, Behrooz
    Mousavi, Bibimaryam
    Macreadie, Ian G.
    JOURNAL OF ALZHEIMERS DISEASE, 2015, 47 (01) : 9 - 16
  • [5] Metal-associated amyloid-β species in Alzheimer's disease
    Pithadia, Amit S.
    Lim, Mi Hee
    CURRENT OPINION IN CHEMICAL BIOLOGY, 2012, 16 (1-2) : 67 - 73
  • [6] Synergy between amyloid-β and tau in Alzheimer's disease
    Busche, Marc Aurel
    Hyman, Bradley T.
    NATURE NEUROSCIENCE, 2020, 23 (10) : 1183 - 1193
  • [7] Interactions between Amyloid-β and Tau in Cerebrospinal Fluid of People with Mild Cognitive Impairment and Alzheimer's Disease
    Kristofikova, Zdena
    Ricny, Jan
    Kolarova, Michaela
    Vyhnalek, Martin
    Hort, Jakub
    Laczo, Jan
    Sirova, Jana
    Ripova, Daniela
    JOURNAL OF ALZHEIMERS DISEASE, 2014, 42 : S91 - S98
  • [8] Pyroglutamylated amyloid-β is associated with hyperphosphorylated tau and severity of Alzheimer's disease
    Mandler, Markus
    Walker, Lauren
    Santic, Radmila
    Hanson, Peter
    Upadhaya, Ajeet Rijal
    Colloby, Sean J.
    Morris, Christopher M.
    Thal, Dietmar R.
    Thomas, Alan J.
    Schneeberger, Achim
    Attems, Johannes
    ACTA NEUROPATHOLOGICA, 2014, 128 (01) : 67 - 79
  • [9] Comparison of Tau and Amyloid-β Targeted Immunotherapy Nanoparticles for Alzheimer's Disease
    Mashal, Yara
    Abdelhady, Hosam
    Iyer, Arun K.
    BIOMOLECULES, 2022, 12 (07)
  • [10] Amyloid-β and tau - a toxic pas de deux in Alzheimer's disease
    Ittner, Lars M.
    Goetz, Juergen
    NATURE REVIEWS NEUROSCIENCE, 2011, 12 (02) : 67 - 72